Search / Trial NCT06615687

Inverted T-shape Free Gingival Graft for Treatment of RT2 / RT3 Gingival Recession Defects

Launched by CAIRO UNIVERSITY · Sep 25, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Inverted T Shape Free Gingival Graft Gingival Recession Free Gingival Graft

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with RT2/RT3 gingival recession.
  • * Indication for FGG treatment at mandibular incisor area (i.e., difficulty or discomfort during oral hygiene; gingival margin mobility; high muscle attachment and/or frenum pull; shallow vestibule and gingival recession.
  • * KT width (KTW) \< 2 mm.
  • * Ages 18-40 years old.
  • * Patients with healthy systemic condition (Brightman. 1994).
  • * Gingival and plaque index \<10.
  • * Good oral hygiene (Wiesner et al. 2010).
  • * Accepts 6 months follow-up period (cooperative patients)
  • Exclusion Criteria:
  • * Smokers.
  • * Poor oral hygiene.
  • * Patient with a physical disability that hinders the upkeep of good oral hygiene measures.
  • * Intake of any medications known to affect gingival homeostasis or to interfere with wound healing.
  • * Pregnant or lactating women.
  • * RT1 gingival recession.
  • * Caries or non-carious cervical lesions at recipient sites.
  • * Severely malpositioned teeth.
  • * Teeth with residual probing depth ≥ 4 mm.
  • * Mobility ≥ 1 mm.
  • * Pervious periodontal surgery within the last 6 months before the start of the trial.
  • * Patients with active periodontal disease. -

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0